Literature DB >> 24740510

Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progression.

Marcus Buggert1, Melissa M Norström, Marco Salemi, Frederick M Hecht, Annika C Karlsson.   

Abstract

Viral escape from HIV-1-specific CD8(+) T cells has been demonstrated in numerous studies previously. However, the qualitative features driving the emergence of mutations within epitopes are still unclear. In this study, we aimed to distinguish whether specific functional characteristics of HLA-B*5701-restricted CD8(+) T cells influence the emergence of mutations in high-risk progressors (HRPs) versus low-risk progressors (LRPs). Single-genome sequencing was performed to detect viral mutations (variants) within seven HLA-B*5701-restricted epitopes in Gag (n = 4) and Nef (n = 3) in six untreated HLA-B*5701 subjects followed from early infection up to 7 y. Several well-characterized effector markers (IFN-γ, IL-2, MIP-1β, TNF, CD107a, and perforin) were identified by flow cytometry following autologous (initial and emerging variant/s) epitope stimulations. This study demonstrates that specific functional attributes may facilitate the outgrowth of mutations within HLA-B*5701-restricted epitopes. A significantly lower fraction of IL-2-producing cells and a decrease in functional avidity and polyfunctional sensitivity were evident in emerging epitope variants compared with the initial autologous epitopes. Interestingly, the HRPs mainly drove these differences, whereas the LRPs maintained a directed and maintained functional response against emerging epitope variants. In addition, LRPs induced improved cell-cycle progression and perforin upregulation after autologous and emerging epitope variant stimulations in contrast to HRPs. The maintained quantitative and qualitative features of the CD8(+) T cell responses in LRPs toward emerging epitope variants provide insights into why HLA-B*5701 subjects have different risks of HIV-1 disease progression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24740510      PMCID: PMC4046013          DOI: 10.4049/jimmunol.1302253

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  Use of laboratory tests and clinical symptoms for identification of primary HIV infection.

Authors:  Frederick M Hecht; Michael P Busch; Bhupat Rawal; Marcy Webb; Eric Rosenberg; Melinda Swanson; Margaret Chesney; Jennifer Anderson; Jay Levy; James O Kahn
Journal:  AIDS       Date:  2002-05-24       Impact factor: 4.177

2.  Combination of immune and viral factors distinguishes low-risk versus high-risk HIV-1 disease progression in HLA-B*5701 subjects.

Authors:  Melissa M Norström; Marcus Buggert; Johanna Tauriainen; Wendy Hartogensis; Mattia C Prosperi; Mark A Wallet; Frederick M Hecht; Marco Salemi; Annika C Karlsson
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

3.  CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells.

Authors:  Nichole R Klatt; Emi Shudo; Alex M Ortiz; Jessica C Engram; Mirko Paiardini; Benton Lawson; Michael D Miller; James Else; Ivona Pandrea; Jacob D Estes; Cristian Apetrei; Joern E Schmitz; Ruy M Ribeiro; Alan S Perelson; Guido Silvestri
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

4.  In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells.

Authors:  Joseph K Wong; Matthew C Strain; Rodin Porrata; Elizabeth Reay; Sumathi Sankaran-Walters; Caroline C Ignacio; Theresa Russell; Satish K Pillai; David J Looney; Satya Dandekar
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

5.  HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition.

Authors:  Toshiyuki Miura; Mark A Brockman; Arne Schneidewind; Michael Lobritz; Florencia Pereyra; Almas Rathod; Brian L Block; Zabrina L Brumme; Chanson J Brumme; Brett Baker; Alissa C Rothchild; Bin Li; Alicja Trocha; Emily Cutrell; Nicole Frahm; Christian Brander; Ildiko Toth; Eric J Arts; Todd M Allen; Bruce D Walker
Journal:  J Virol       Date:  2008-12-30       Impact factor: 5.103

6.  TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection.

Authors:  Huabiao Chen; Zaza M Ndhlovu; Dongfang Liu; Lindsay C Porter; Justin W Fang; Sam Darko; Mark A Brockman; Toshiyuki Miura; Zabrina L Brumme; Arne Schneidewind; Alicja Piechocka-Trocha; Kevin T Cesa; Jennifer Sela; Thai D Cung; Ildiko Toth; Florencia Pereyra; Xu G Yu; Daniel C Douek; Daniel E Kaufmann; Todd M Allen; Bruce D Walker
Journal:  Nat Immunol       Date:  2012-06-10       Impact factor: 25.606

7.  A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells.

Authors:  Kristin Ladell; Masao Hashimoto; Maria Candela Iglesias; Pascal G Wilmann; James E McLaren; Stéphanie Gras; Takayuki Chikata; Nozomi Kuse; Solène Fastenackels; Emma Gostick; John S Bridgeman; Vanessa Venturi; Zaïna Aït Arkoub; Henri Agut; David J van Bockel; Jorge R Almeida; Daniel C Douek; Laurence Meyer; Alain Venet; Masafumi Takiguchi; Jamie Rossjohn; David A Price; Victor Appay
Journal:  Immunity       Date:  2013-03-21       Impact factor: 31.745

8.  Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection.

Authors:  Guido Ferrari; Bette Korber; Nilu Goonetilleke; Michael K P Liu; Emma L Turnbull; Jesus F Salazar-Gonzalez; Natalie Hawkins; Steve Self; Sydeaka Watson; Michael R Betts; Cynthia Gay; Kara McGhee; Pierre Pellegrino; Ian Williams; Georgia D Tomaras; Barton F Haynes; Clive M Gray; Persephone Borrow; Mario Roederer; Andrew J McMichael; Kent J Weinhold
Journal:  PLoS Pathog       Date:  2011-02-10       Impact factor: 6.823

9.  Common genetic variation and the control of HIV-1 in humans.

Authors:  Jacques Fellay; Dongliang Ge; Kevin V Shianna; Sara Colombo; Bruno Ledergerber; Elizabeth T Cirulli; Thomas J Urban; Kunlin Zhang; Curtis E Gumbs; Jason P Smith; Antonella Castagna; Alessandro Cozzi-Lepri; Andrea De Luca; Philippa Easterbrook; Huldrych F Günthard; Simon Mallal; Cristina Mussini; Judith Dalmau; Javier Martinez-Picado; José M Miro; Niels Obel; Steven M Wolinsky; Jeremy J Martinson; Roger Detels; Joseph B Margolick; Lisa P Jacobson; Patrick Descombes; Stylianos E Antonarakis; Jacques S Beckmann; Stephen J O'Brien; Norman L Letvin; Andrew J McMichael; Barton F Haynes; Mary Carrington; Sheng Feng; Amalio Telenti; David B Goldstein
Journal:  PLoS Genet       Date:  2009-12-24       Impact factor: 5.917

10.  Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells.

Authors:  Hendrik Streeck; Zabrina L Brumme; Michael Anastario; Kristin W Cohen; Jonathan S Jolin; Angela Meier; Chanson J Brumme; Eric S Rosenberg; Galit Alter; Todd M Allen; Bruce D Walker; Marcus Altfeld
Journal:  PLoS Med       Date:  2008-05-06       Impact factor: 11.069

View more
  7 in total

1.  Frequencies of Gag-restricted T-cell escape "footprints" differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles.

Authors:  Jennifer Serwanga; Ritah Nakiboneka; Susan Mugaba; Brian Magambo; Nicaise Ndembi; Frances Gotch; Pontiano Kaleebu
Journal:  Vaccine       Date:  2015-02-26       Impact factor: 3.641

2.  Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals.

Authors:  Johanna Tauriainen; Lydia Scharf; Juliet Frederiksen; Ali Naji; Hans-Gustaf Ljunggren; Anders Sönnerborg; Ole Lund; Gustavo Reyes-Terán; Frederick M Hecht; Steven G Deeks; Michael R Betts; Marcus Buggert; Annika C Karlsson
Journal:  Sci Rep       Date:  2017-01-13       Impact factor: 4.379

3.  Immune Signature of Enhanced Functional Avidity CD8+ T Cells in vivo Induced by Vaccinia Vectored Vaccine.

Authors:  Zhidong Hu; Lingyan Zhu; Jing Wang; Yanmin Wan; Songhua Yuan; Jian Chen; Xiangqing Ding; Chenli Qiu; Xiaoyan Zhang; Chao Qiu; Jianqing Xu
Journal:  Sci Rep       Date:  2017-02-03       Impact factor: 4.379

4.  Delayed Expression of PD-1 and TIGIT on HIV-Specific CD8 T Cells in Untreated HLA-B*57:01 Individuals Followed from Early Infection.

Authors:  Lydia Scharf; Johanna Tauriainen; Marcus Buggert; Wendy Hartogensis; David J Nolan; Steven G Deeks; Marco Salemi; Frederick M Hecht; Annika C Karlsson
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

Review 5.  The influence of HLA/HIV genetics on the occurrence of elite controllers and a need for therapeutics geotargeting view.

Authors:  Luciano Werle Lunardi; Marcelo Alves de Souza Bragatte; Gustavo Fioravanti Vieira
Journal:  Braz J Infect Dis       Date:  2021-09-22       Impact factor: 3.257

6.  T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection.

Authors:  Marcus Buggert; Johanna Tauriainen; Takuya Yamamoto; Juliet Frederiksen; Martin A Ivarsson; Jakob Michaëlsson; Ole Lund; Bo Hejdeman; Marianne Jansson; Anders Sönnerborg; Richard A Koup; Michael R Betts; Annika C Karlsson
Journal:  PLoS Pathog       Date:  2014-07-17       Impact factor: 6.823

7.  CD4+ T cells with an activated and exhausted phenotype distinguish immunodeficiency during aviremic HIV-2 infection.

Authors:  Marcus Buggert; Juliet Frederiksen; Ole Lund; Michael R Betts; Antonio Biague; Morten Nielsen; Johanna Tauriainen; Hans Norrgren; Patrik Medstrand; Annika C Karlsson; Marianne Jansson
Journal:  AIDS       Date:  2016-10-23       Impact factor: 4.177

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.